Paper218151
Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.
Nachtigall LE and 3 others. Obstet Gynecol, 1979. Cited by 363 papers, by iCite.
Cite this record
ConductScience Library. Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis. Papers, record 218151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/218151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Estrogens, Conjugated (USP) | Major topic |
| Medroxyprogesterone | Major topic |
| Menopause | Major topic |
| Osteoporosis | Major topic |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Prospective Studies | |
| Time Factors |
Source PubMed
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 363 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35409368 | Sex Differences in Cardiovascular Diseases: A Matter of Estrogens, Ceramides, and Sphingosine 1-Phosphate. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409368 | PubMed |
| 30216118 | A heartfelt message, estrogen replacement therapy: use it or lose it. | Am J Physiol Heart Circ Physiol | 2018 | https://conductscience.org/library/papers/30216118 | PubMed |
| 27322315 | Osteoporosis: Modern Paradigms for Last Century's Bones. | Nutrients | 2016 | https://conductscience.org/library/papers/27322315 | PubMed |
| 24910928 | Menopausal hormone therapy and cancer: changing clinical observations of target site specificity. | Steroids | 2014 | https://conductscience.org/library/papers/24910928 | PubMed |
| 23315354 | Pharmacokinetics of estradiol valerate 2mg + dienogest 2mg (climodien® 2/2) after single and repeated oral administration in healthy postmenopausal women. | Clin Drug Investig | 2000 | https://conductscience.org/library/papers/23315354 | PubMed |
| 22427684 | Changing concepts: Menopausal hormone therapy and breast cancer. | J Natl Cancer Inst | 2012 | https://conductscience.org/library/papers/22427684 | PubMed |
| 21267140 | Estrogen replacement therapy for postmenopausal osteoporosis. | Can Fam Physician | 1986 | https://conductscience.org/library/papers/21267140 | PubMed |
| 21153101 | Salmon calcitonin nasal spray : An effective alternative to estrogen therapy in select postmenopausal women. | Endocrine | 1996 | https://conductscience.org/library/papers/21153101 | PubMed |
| 20469458 | A rationale for the current management of post-menopausal osteoporosis. | Can Fam Physician | 1986 | https://conductscience.org/library/papers/20469458 | PubMed |
| 16626523 | Canadian Consensus Conference on osteoporosis, 2006 update. | J Obstet Gynaecol Can | 2006 | https://conductscience.org/library/papers/16626523 | PubMed |
| 15542889 | Hormones and bone health in postmenopausal women. | Endocrine | 2004 | https://conductscience.org/library/papers/15542889 | PubMed |
| 14534773 | Predicting the effects of estrogen replacement therapy on lumbar bone mineral density in oophorectomized women: analysis of a 10-year longitudinal study. | Osteoporos Int | 2003 | https://conductscience.org/library/papers/14534773 | PubMed |
| 11788576 | Guidelines on the management of osteoporosis associated with chronic liver disease. | Gut | 2002 | https://conductscience.org/library/papers/11788576 | PubMed |
| 11465306 | Hip fracture prevention: cost-effective strategies. | Pharmacoeconomics | 2001 | https://conductscience.org/library/papers/11465306 | PubMed |
| 11087009 | Preventing fractures in postmenopausal women with osteoporosis. A review of recent controlled trials of antiresorptive agents. | Drugs Aging | 2000 | https://conductscience.org/library/papers/11087009 | PubMed |
| 10150160 | Translating safety, efficacy and compliance into economic value for controlled release dosage forms. | Pharmacoeconomics | 1994 | https://conductscience.org/library/papers/10150160 | PubMed |
| 9225138 | Use of estrogen for prevention and treatment of osteoporosis. | Endocrine | 1997 | https://conductscience.org/library/papers/9225138 | PubMed |
| 9205638 | Hormone replacement therapy in the prevention and treatment of osteoporosis. | Osteoporos Int | 1997 | https://conductscience.org/library/papers/9205638 | PubMed |
| 8873639 | Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada. | CMAJ | 1996 | https://conductscience.org/library/papers/8873639 | PubMed |
| 8800784 | Changes in bone density in women starting hormone replacement therapy compared with those in women already established on hormone replacement therapy. | Osteoporos Int | 1995 | https://conductscience.org/library/papers/8800784 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/218151
GET https://conductscience.org/api/papers/v1/218151/cited_by?page=2